Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1054


Prominence of Pairing in Inclusive (p,2p) and (p,pn) Cross Sections from Neutron-Rich Nuclei.

Paul N, Obertelli A, Bertulani CA, Corsi A, Doornenbal P, Rodriguez-Sanchez JL, Authelet G, Baba H, Calvet D, Château F, Chen S, Delbart A, Gheller JM, Giganon A, Gillibert A, Isobe T, Lapoux V, Matsushita M, Momiyama S, Motobayashi T, Niikura M, Otsu H, Péron C, Peyaud A, Pollacco EC, Roussé JY, Sakurai H, Santamaria C, Sasano M, Shiga Y, Steppenbeck D, Takeuchi S, Taniuchi R, Uesaka T, Wang H, Yoneda K, Ando T, Arici T, Blazhev A, Browne F, Bruce AM, Carroll R, Chung LX, Cortés ML, Dewald M, Ding B, Dombradi Z, Flavigny F, Franchoo S, Giacoppo F, Górska M, Gottardo A, Hadynska-Klek K, Korkulu Z, Koyama S, Kubota Y, Jungclaus A, Lee J, Lettmann M, Linh BD, Liu J, Liu Z, Lizarazo C, Louchart C, Lozeva R, Matsui K, Miyazaki T, Moschner K, Nagamine S, Nakatsuka N, Nita C, Nishimura S, Nobs CR, Olivier L, Ota S, Patel Z, Podolyák Z, Rudigier M, Sahin E, Saito TY, Shand C, Söderström PA, Stefan IG, Sumikama T, Suzuki D, Orlandi R, Vaquero V, Vajta Z, Werner V, Wimmer K, Wu J, Xu Z.

Phys Rev Lett. 2019 Apr 26;122(16):162503. doi: 10.1103/PhysRevLett.122.162503.


MR Imaging-based Evaluation of Mesenteric Ischemia Caused by Strangulated Small Bowel Obstruction and Mesenteric Venous Occlusion: An Experimental Study Using Rabbits.

Inoue A, Nitta N, Ota S, Takaki K, Imai Y, Misaki S, Iwai T, Sonoda A, Mukaisho KI, Murata K.

Magn Reson Med Sci. 2019 May 7. doi: 10.2463/ [Epub ahead of print]


Symptomatic bone marrow lesions induced by reduced bone mineral density in middle-aged women: a cross-sectional Japanese population study.

Ota S, Chiba D, Sasaki E, Kumagai G, Yamamoto Y, Nakaji S, Tsuda E, Ishibashi Y.

Arthritis Res Ther. 2019 May 6;21(1):113. doi: 10.1186/s13075-019-1900-4.


78Ni revealed as a doubly magic stronghold against nuclear deformation.

Taniuchi R, Santamaria C, Doornenbal P, Obertelli A, Yoneda K, Authelet G, Baba H, Calvet D, Château F, Corsi A, Delbart A, Gheller JM, Gillibert A, Holt JD, Isobe T, Lapoux V, Matsushita M, Menéndez J, Momiyama S, Motobayashi T, Niikura M, Nowacki F, Ogata K, Otsu H, Otsuka T, Péron C, Péru S, Peyaud A, Pollacco EC, Poves A, Roussé JY, Sakurai H, Schwenk A, Shiga Y, Simonis J, Stroberg SR, Takeuchi S, Tsunoda Y, Uesaka T, Wang H, Browne F, Chung LX, Dombradi Z, Franchoo S, Giacoppo F, Gottardo A, Hadyńska-Klęk K, Korkulu Z, Koyama S, Kubota Y, Lee J, Lettmann M, Louchart C, Lozeva R, Matsui K, Miyazaki T, Nishimura S, Olivier L, Ota S, Patel Z, Şahin E, Shand C, Söderström PA, Stefan I, Steppenbeck D, Sumikama T, Suzuki D, Vajta Z, Werner V, Wu J, Xu ZY.

Nature. 2019 May;569(7754):53-58. doi: 10.1038/s41586-019-1155-x. Epub 2019 May 1.


Phase I/II pilot study of WT1 peptide-pulsed dendritic cell vaccination combined with conventional chemotherapy in patients with head and neck cancer.

Ogasawara M, Miyashita M, Yamagishi Y, Ota S.

Ther Apher Dial. 2019 Apr 29. doi: 10.1111/1744-9987.12831. [Epub ahead of print]


Prevalence of cervical canal stenosis in farmers: Epidemiological study based on radiographic parameter of spinal cord injury patients.

Wada K, Kumagai G, Kudo H, Asari T, Ota S, Kamei K, Koyama K, Nakaji S, Ishibashi Y.

J Orthop Sci. 2019 Apr 15. pii: S0949-2658(19)30114-9. doi: 10.1016/j.jos.2019.03.021. [Epub ahead of print]


Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis.

Kano M, Hayano K, Hayashi H, Hanari N, Gunji H, Toyozumi T, Murakami K, Uesato M, Ota S, Matsubara H.

Ann Surg Oncol. 2019 Jun;26(6):1805-1813. doi: 10.1245/s10434-019-07299-7. Epub 2019 Apr 11.


Change in hepatic hemodynamics assessed by hepatic arterial blood pressure and computed tomography during hepatic angiography with the double balloon technique.

Inoue A, Ota S, Takaki K, Imai Y, Sato S, Watanabe S, Tomozawa Y, Iwai T, Murakami Y, Sonoda A, Nitta N, Murata K.

Jpn J Radiol. 2019 Mar 29. doi: 10.1007/s11604-019-00836-0. [Epub ahead of print]


Predicting radiological vertebral fractures with a combined physical function and body composition scoring system.

Takeda O, Kumagai G, Wada K, Kudo H, Asari T, Ota S, Chiba D, Nakaji S, Ishibashi Y.

J Bone Miner Metab. 2019 Mar 27. doi: 10.1007/s00774-019-00998-x. [Epub ahead of print]


Release of silicone oil and the off-label use of syringes in ophthalmology.

Melo GB, Emerson GG, Dias CS Jr, Morais FB, Lima Filho AS, Ota S, Farah ME, Rodrigues EB, Maia M, Belfort R Jr.

Br J Ophthalmol. 2019 Mar 25. pii: bjophthalmol-2019-313823. doi: 10.1136/bjophthalmol-2019-313823. [Epub ahead of print]


Immunomodulator-associated Epstein-Barr virus-positive mucocutaneous ulcer in a patient with refractory Crohn's disease.

Hamanaka S, Nakagawa T, Ota S, Iida M, Ohta Y, Isshiki Y, Kasamatsu S, Ishigami H, Taida T, Okimoto K, Saito K, Maruoka D, Matsumura T, Ohwada C, Takeuchi M, Sakaida E, Arai M, Katsuno T, Nakaseko C, Nakatani Y, Kato N.

Clin J Gastroenterol. 2019 Mar 22. doi: 10.1007/s12328-019-00952-4. [Epub ahead of print]


Dynamic magnetic characterization and magnetic particle imaging enhancement of magnetic-gold core-shell nanoparticles.

Tomitaka A, Ota S, Nishimoto K, Arami H, Takemura Y, Nair M.

Nanoscale. 2019 Mar 28;11(13):6489-6496. doi: 10.1039/c9nr00242a.


ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation.

Kimura F, Kanda J, Ishiyama K, Yabe T, Yoshifuji K, Fukuda T, Ozawa Y, Iwato K, Eto T, Mori T, Uchida N, Ota S, Sakura T, Ichinohe T, Atsuta Y, Kanda Y; donor/source working group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Mar 13. doi: 10.1038/s41409-019-0496-2. [Epub ahead of print]


Key ^{19}Ne States Identified Affecting γ-Ray Emission from ^{18}F in Novae.

Hall MR, Bardayan DW, Baugher T, Lepailleur A, Pain SD, Ratkiewicz A, Ahn S, Allen JM, Anderson JT, Ayangeakaa AD, Blackmon JC, Burcher S, Carpenter MP, Cha SM, Chae KY, Chipps KA, Cizewski JA, Febbraro M, Hall O, Hu J, Jiang CL, Jones KL, Lee EJ, O'Malley PD, Ota S, Rasco BC, Santiago-Gonzalez D, Seweryniak D, Sims H, Smith K, Tan WP, Thompson P, Thornsberry C, Varner RL, Walter D, Wilson GL, Zhu S.

Phys Rev Lett. 2019 Feb 8;122(5):052701. doi: 10.1103/PhysRevLett.122.052701.


Obstetric complication-associated ANXA5 promoter polymorphisms may affect gene expression via DNA secondary structures.

Inagaki H, Ota S, Nishizawa H, Miyamura H, Nakahira K, Suzuki M, Nishiyama S, Kato T, Yanagihara I, Kurahashi H.

J Hum Genet. 2019 May;64(5):459-466. doi: 10.1038/s10038-019-0578-4. Epub 2019 Feb 22.


Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI Therapy.

Seki N, Natsume M, Ochiai R, Haruyama T, Ishihara M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ota S, Ichikawa Y, Watanabe K.

Case Rep Oncol. 2019 Jan 21;12(1):91-97. doi: 10.1159/000493088. eCollection 2019 Jan-Apr.


Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush.

Seki N, Ochiai R, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ota S, Ichikawa Y, Watanabe K.

Case Rep Oncol. 2019 Jan 21;12(1):84-90. doi: 10.1159/000493256. eCollection 2019 Jan-Apr.


Significance of Earlier Initiation of Chemotherapy for Lung Cancer Complicated with Primary or Secondary Nephrotic Syndrome following Its Appropriate Differential Diagnosis.

Ota S, Fujigaki Y, Tamura Y, Kojima K, Ochiai R, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ichikawa Y, Watanabe K, Seki N.

Case Rep Oncol. 2019 Jan 11;12(1):53-58. doi: 10.1159/000493851. eCollection 2019 Jan-Apr.


Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature Review.

Ota S, Sakamoto T, Ochiai R, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Tanzawa S, Usui R, Honda T, Ichikawa Y, Watanabe K, Sasajima Y, Mizota A, Seki N.

Case Rep Oncol. 2019 Jan 11;12(1):47-52. doi: 10.1159/000493850. eCollection 2019 Jan-Apr.


Serum level of soluble interleukin-2 receptor is positively correlated with metabolic tumor volume on 18 F-FDG PET/CT in newly diagnosed patients with diffuse large B-cell lymphoma.

Senjo H, Kanaya M, Izumiyama K, Minauchi K, Hirata K, Mori A, Saito M, Tanaka M, Iijima H, Tsukamoto E, Itoh K, Ota S, Morioka M, Hashimoto D, Teshima T; North Japan Hematology Study Group (NJHSG).

Cancer Med. 2019 Mar;8(3):953-962. doi: 10.1002/cam4.1973. Epub 2019 Feb 20.

Supplemental Content

Support Center